Transthyretin Amyloidosis Latest Advances

Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 15, 2026

Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: June 09, 2026

Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 03, 2026

Geyserlike OCT Sign in Transthyretin Amyloidosis.

Journal: JAMA ophthalmology

Published: May 28, 2026

Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

Journal: Circulation. Cardiovascular imaging

Published: May 27, 2026

Comments on "Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials".

Journal: Therapeutic advances in cardiovascular disease

Published: May 21, 2026

Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.

Journal: Journal of the neurological sciences

Published: May 19, 2026

Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry.

Journal: International heart journal

Published: May 17, 2026

Bat Wing Sign: Pulmonary Bleeding in Transthyretin Amyloidosis.

Journal: Internal medicine (Tokyo, Japan)

Published: May 17, 2026

Coexistence of Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Transthyretin Amyloidosis in an Elderly Japanese Patient With Splenic Marginal Zone Lymphoma: An Autopsy Case Report.

Journal: Cureus

Published: May 17, 2026

Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.

Journal: Circulation. Heart failure

Published: May 09, 2026

The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis.

Journal: Acta cardiologica

Published: May 08, 2026

Transthyretin Amyloidosis Latest Advances

Find the Latest Research About Transthyretin Amyloidosis

Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.

Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.

Geyserlike OCT Sign in Transthyretin Amyloidosis.

Geyserlike OCT Sign in Transthyretin Amyloidosis.

Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

Comments on "Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials".

Comments on "Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials".

Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.

Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.

Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry.

Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry.

Bat Wing Sign: Pulmonary Bleeding in Transthyretin Amyloidosis.

Bat Wing Sign: Pulmonary Bleeding in Transthyretin Amyloidosis.

Coexistence of Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Transthyretin Amyloidosis in an Elderly Japanese Patient With Splenic Marginal Zone Lymphoma: An Autopsy Case Report.

Coexistence of Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Transthyretin Amyloidosis in an Elderly Japanese Patient With Splenic Marginal Zone Lymphoma: An Autopsy Case Report.

Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.

Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.

The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis.

The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis.